Science Explorer Back to mapMap
Discussion
Researcher · Meikai University · Japan

Masayoshi Kumegawa

Masayoshi Kumegawa publishes mostly in Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism, on topics such as Bone Metabolism and Diseases, Bone health and treatments and Inflammatory mediators and NSAID effects.

OpenAlex
World rank
#1,113,138
of 7,710,434 ranked researchers
Rank in Japan
#15,657
of 383,136
Works
300
Citations
12k
Citations per work
38.7
h-index
58
i10-index 164Top 2.3% in Molecular Biology
Masayoshi Kumegawa

What does Masayoshi Kumegawa research?

Masayoshi Kumegawa's work is mostly in Biochemistry, Genetics and Molecular Biology (31%), Medicine (24%).

Everything else: 134 works · 44.7% of their workLife Sciences: 92 works · 30.8% of their workBiochemistry, Genetics and Molecular Biology: 92 works · 30.8% of their workMolecular Biology: 76 works · 25.5% of their workGenetics: 16 works · 5.3% of their workHealth Sciences: 74 works · 24.5% of their workMedicine: 74 works · 24.5% of their workOncology: 28 works · 9.4% of their workEndocrinology, Diabetes and Metabolism: 18 works · 6.0% of their workRheumatology: 15 works · 5.0% of their workPhysiology: 12 works · 4.1% of their workTHEIR WORKMasayoshiKumegawa300works
Life Sciences31%Health Sciences24%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else13444.7%
    1. Biochemistry, Genetics and Molecular Biology9230.8%
    1. Medicine7424.5%
  1. 1Molecular Biology26% of their works
  2. 2Oncology9% of their works
  3. 3Endocrinology, Diabetes and Metabolism6% of their works
  4. 4Genetics5% of their works
  5. 5Rheumatology5% of their works
  6. 6Physiology4% of their works

Research topics

Which keywords describe Masayoshi Kumegawa's research?

The keywords of their largest research topics: Bone Resorption, Osteoclast Differentiation, Breast Cancer, Inflammation, Bisphosphonates, Osteonecrosis of the Jaw, Biomineralization and Osteopontin.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Bone Resorption741 topic
  2. Osteoclast Differentiation741 topic
  3. Breast Cancer682 topics
  4. Inflammation683 topics
  5. Bisphosphonates531 topic
  6. Osteonecrosis of the Jaw531 topic
  7. Biomineralization422 topics
  8. Osteopontin422 topics
  9. Cancer261 topic
  10. Cell Signaling261 topic
  11. Cyclooxygenase-2 Inhibitors261 topic
  12. Matricellular Proteins261 topic
  13. Bone Mineral Density201 topic
  14. Fractures201 topic
  15. Alkaline Phosphatase161 topic
  16. Bone Mineralization161 topic
  17. Diagnostic Criteria161 topic
  18. Saliva161 topic
  19. Estrogen151 topic
  20. Receptor151 topic

Where does Masayoshi Kumegawa work?

Masayoshi Kumegawa's main affiliation in the publication record is Meikai University, Japan.

How many publications and citations does Masayoshi Kumegawa have?

OpenAlex counts 300 works and 11,606 citations for Masayoshi Kumegawa, an h-index of 58, ranking #1,113,138 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Masayoshi Kumegawa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.